The UCSF Osher Center of Integrative Medicine today announced the appointment of Donald I. Abrams, MD, professor of clinical medicine, as the center's new director of clinical programs.
UCSF's Arnold Kriegstein, MD, PhD, director of the UCSF Institute for Regeneration Medicine, participated in a small roundtable lunch meeting yesterday at Genentech Inc. with biotechnology leaders from the region and British Prime Minister Tony Blair.
The San Francisco Chronicle profiles Yiming Shao, MD, PhD, director of virology and immunology at the National Center for AIDS/STD Control and Prevention in Beijing, and his long professional relationship with Jay Levy, MD.
The efforts of Mort Cowan, MD, director of UCSF's Pediatric Bone Marrow Transplant Program, were explored in an article by Rick Halstead in the Marin Independent Journal.
Four nurse-scholars with the UCSF/John A. Hartford Center of Geriatric Nursing Excellence have been awarded scholarships of $100,000 or fellowships of $125,000 to allow them to make a two-year, full-time commitment to research, teaching and leadership in geriatric nursing.
Older patients with atrial fibrillation have higher rates of major hemorrhage in the brain whether or not they are using a common blood thinning therapy, according to a new study.
Marc Safran, MD, who heads the Sports Medicine Center, spoke with KPIX-TV/CBS 5 about cyclist Floyd Landis's comments to Sports Illustrated in the wake of an abnormal testosterone to epitestosterone level.
At the World Transplant Congress (WTC) in Boston on July 24, Stephen Tomlanovich, MD, presented the findings of a three-month, prospective, open-label, two-cohort research study in which renal transplant patients were switched from mycophenolate mofetil (MMF) to enteric-coated myfortic, reducing the incidence and severity of gastrointestinal complications.
The number of Americans stricken by a deadly and debilitating bone-thinning disease continues to climb. According to a 2004 Surgeon General's report, more than half of Americans age 50 and older are at risk for osteoporosis – porous bones.